Cargando…
Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge
Diabetic nephropathy is the most common cause of end-stage renal disease worldwide. Control of blood glucose and blood pressure (BP) reduces the risk of developing this complication, but once diabetic nephropathy is established, it is then only possible to slow its progression. Sodium-glucose cotran...
Autores principales: | Provenzano, Michele, Pelle, Maria Chiara, Zaffina, Isabella, Tassone, Bruno, Pujia, Roberta, Ricchio, Marco, Serra, Raffaele, Sciacqua, Angela, Michael, Ashour, Andreucci, Michele, Arturi, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212983/ https://www.ncbi.nlm.nih.gov/pubmed/34150796 http://dx.doi.org/10.3389/fmed.2021.654557 |
Ejemplares similares
-
Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment
por: Pelle, Maria Chiara, et al.
Publicado: (2021) -
Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus
por: Pelle, Maria Chiara, et al.
Publicado: (2023) -
COVID-19 and diabetes—Two giants colliding: From pathophysiology to management
por: Pelle, Maria Chiara, et al.
Publicado: (2022) -
Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
por: Zaffina, Isabella, et al.
Publicado: (2023) -
Up-Date on Diabetic Nephropathy
por: Pelle, Maria Chiara, et al.
Publicado: (2022)